Log in to save to my catalogue

Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic...

Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1851295028

Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)

About this item

Full title

Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)

Publisher

Cham: Springer International Publishing

Journal title

Targeted oncology, 2017-02, Vol.12 (1), p.123-123

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Alternative Titles

Full title

Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1851295028

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1851295028

Other Identifiers

ISSN

1776-2596

E-ISSN

1776-260X

DOI

10.1007/s11523-016-0473-2

How to access this item